April 29, 2020
As per the report titled ‘Global Cardiac mapping Market Size study, by Product (Contact Cardiac mapping systems, Non-contact Cardiac mapping systems), by Indication (Atrial Fibrillation, Atrial Flutter, AVNRT, Other Arrhythmias) and Regional Forecasts 2019-2026’, available with Market Study Report LLC, global cardiac mapping market was worth USD 1.3 billion in 2018 and is estimated to expand with a CAGR of 8.7% during 2019-2026.
Cardiac mapping is a highly advanced process used for collecting and displaying of the gathered data from an electrocardiogram (ECG). The primary purpose of cardiac mapping system is to monitor the coordination between heart beats and electric impulses. Technological advancements in the cardiac mapping systems such as integration of intelligent automation tools have resulted in reduced mapping time, thereby boosting the product adoption.
Rising geriatric population and their susceptibility towards several health concerns including cardiac complications are driving the global cardiac mapping market growth. As per a WHO report, annual number of CVD (cardiovascular disease) deaths across the globe reached 17.9 million in 2016 and is anticipated to increase to 24.2 million by 2030. Likewise, as per Our World in Data organization, worldwide cardiovascular disease burden increased from 302 million in 2001 to 365 million in 2017. Soaring number of patients suffering from cardiac conditions such as hypertrophic cardiomyopathy, coronary artery disease, myocardial infarction, and arrhythmia will continue to fuel demand for cardiac mapping throughout the forecast duration.
On the contrary, lack of proper healthcare infrastructure in emerging nations coupled with high cost of cardiac mapping systems will hinder the market growth during the forecast period.
Considering the geographical landscape, global cardiac mapping market is segmented into North America, Europe, Asia Pacific, Latin America and rest of the world. Cardiac mapping market in North America is anticipated to grow considerably, due to higher prevalence of heart disorders and increase in approval rate of mapping systems in the region.
Request sample copy of this Report@ https://www.marketstudyreport.com/request-a-sample/2511055/
Meanwhile, Asia Pacific cardiac mapping market is also slated to exhibit strong growth in the coming years, owing to increasing patient pool for CVDs, escalating demand for advanced systems, and improving healthcare infrastructure.
Key players in global cardiac mapping market are Biosense Webster, Inc., Medtronic Plc, Abbott Laboratories, Microport Scientific Corporation, Boston Scientific Corporation, Acutus Medical, EP Solutions SA, Koninklijke Philips N.V., Biotronik, and Lepu Medical Technology (Beijing) Co., Ltd.